JigneshDDalalMD

Pediatric Hematology & Oncology • Kansas City, MO

Professor, Pediatrics, Case Western Reserve University,Cleveland Ohio. Director Pediatric BMT

Join to view full profile

Dr. Dalal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dalal's full profile

Already have an account?

Office
2401 Gillham Rd
Kansas City, MO 64108
Phone+1 816-234-3000

Fax+1 216-767-8778

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Stony Brook Medicine/University HospitalResidency, Pediatrics, 1995 - 1998
N.H.L Municipal Medical CollegeClass of 1986

Certifications & Licensure

MO State Medical License 2002 - 2025
OH State Medical License 2015 - 2025
TX State Medical License 2002 - 2006
MD State Medical License 1999 - 2002
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Start of enrollment: 2001 Dec 01
Recruiting
Phase 1, Phase 2
Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
Completed
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma Start of enrollment: 2012 Oct 01
Completed
Phase 1
Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors Start of enrollment: 2011 Oct 01
Completed
Phase 1
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) Start of enrollment: 2017 Oct 03
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic ...
Prarthana Dalal, Jignesh Dalal
Leukemia & Lymphoma. 2024-12-01
10 citations
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias.
Juan C Fierro-Pineda, Hua-Ling Tsai, Amanda Blackford, Andrew Cluster, Emi Caywood
Blood Advances. 2023-09-26
Editorial: Advances in the treatment of chronic myeloid leukemia.
Ahmet Emre Eşkazan, Chung H Kok, David Yeung, Jignesh Dalal, Mario Tiribelli
Frontiers in Oncology. 2023-01-01

Abstracts/Posters

Increased Toxicity Among Adolescents and Young Adults Treated for Acute Myeloid Leukemia at US Children's Hospitals
Jignesh Dalal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Preemptive Administration of Ruxolitinib Rapidly Ameliorate Gvhd after Allo-Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study
Jignesh Dalal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Cathelicidin Antimicrobial Peptide Expression Is Inversely Associated with Absolute Neutrophil Counts in Pediatric HCT Recipients
Jignesh Dalal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Outcomes and Healthcare Utilization of Children with Mucopolysaccharidosis with and without Hematopoietic Stem Cell Transplantation
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

University Hospitals Doctor Conducting Clinical Trial for Sickle Cell DiseaseNovember 5th, 2023